Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kent

Showing results (101-110 of 268) with videos related to

Pageof 27
Sort By:
AIDS Patient Care and Stds|April 10, 2015
Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV Patients on StatinsMartin Krsak, David M Kent, Norma Terrin, et al.
BMC Medical Research Methodology|March 28, 2023
Estimating individualized treatment effects from randomized controlled trials: a simulation study to compare risk-based approachesAlexandros Rekkas, Peter R Rijnbeek, David M Kent, et al.
Stroke|December 1, 2004
Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trialsDavid M Kent, Lori Lyn Price, Peter Ringleb, et al.
Transplantation Direct|November 6, 2023
A Clinical Model to Predict the Occurrence of Select High-risk Infections in the First Year Following Heart TransplantationWhitney A Perry, Jennifer K Chow, Jason Nelson, et al.
Stroke|April 17, 2004
In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous?David M Kent, Judith Hinchey, Lori Lyn Price, et al.
The American Journal of Managed Care|April 17, 2015
Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequencesPei-Jung Lin, David M Kent, Aaron Winn, et al.
International Journal of Epidemiology|November 29, 2025
Diverging conclusions from risk difference and difference in restricted mean survival time in quantifying absolute treatment effect heterogeneityCarolien C H M Maas, David M Kent, Avinash G Dinmohamed, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 12, 2017
Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction ModelsNatalia Olchanski, Joshua T Cohen, Peter J Neumann, et al.
JAMA Network Open|July 22, 2025
Predictive Modeling of Heterogeneous Treatment Effects in RCTs: A Scoping ReviewJoe V Selby, Carolien C H M Maas, Bruce H Fireman, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Quantifying absolute treatment effect heterogeneity for time-to-event outcomes across different risk strata: divergence of conclusions with risk difference and restricted mean survival differenceCarolien C H M Maas, David M Kent, Avinash G Dinmohamed, et al.
Pageof 27

Showing results (101-110 of 268) with videos related to

Sort By:
Pageof 27
AIDS Patient Care and Stds|April 10, 2015
Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV Patients on StatinsMartin Krsak, David M Kent, Norma Terrin, et al.
BMC Medical Research Methodology|March 28, 2023
Estimating individualized treatment effects from randomized controlled trials: a simulation study to compare risk-based approachesAlexandros Rekkas, Peter R Rijnbeek, David M Kent, et al.
Stroke|December 1, 2004
Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trialsDavid M Kent, Lori Lyn Price, Peter Ringleb, et al.
Transplantation Direct|November 6, 2023
A Clinical Model to Predict the Occurrence of Select High-risk Infections in the First Year Following Heart TransplantationWhitney A Perry, Jennifer K Chow, Jason Nelson, et al.
Stroke|April 17, 2004
In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous?David M Kent, Judith Hinchey, Lori Lyn Price, et al.
The American Journal of Managed Care|April 17, 2015
Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequencesPei-Jung Lin, David M Kent, Aaron Winn, et al.
International Journal of Epidemiology|November 29, 2025
Diverging conclusions from risk difference and difference in restricted mean survival time in quantifying absolute treatment effect heterogeneityCarolien C H M Maas, David M Kent, Avinash G Dinmohamed, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 12, 2017
Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction ModelsNatalia Olchanski, Joshua T Cohen, Peter J Neumann, et al.
JAMA Network Open|July 22, 2025
Predictive Modeling of Heterogeneous Treatment Effects in RCTs: A Scoping ReviewJoe V Selby, Carolien C H M Maas, Bruce H Fireman, et al.
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Quantifying absolute treatment effect heterogeneity for time-to-event outcomes across different risk strata: divergence of conclusions with risk difference and restricted mean survival differenceCarolien C H M Maas, David M Kent, Avinash G Dinmohamed, et al.
Pageof 27